Fractal Analytics Ltd, a newly listed Indian AI and analytics company, reported a profit after tax (PAT) of ₹100 crore in its first quarterly results since its stock market debut on February 16, 2026. The results cover the third quarter of FY 2026 (October–December 2025) and mark a strong start for the company as a publicly traded firm.
The company’s revenue rose 21% year‑on‑year to ₹854.4 crore, driven by growing demand from clients in healthcare, life sciences, and banking and financial services (BFSI) sectors. Healthcare alone contributed significantly, with revenue rising nearly 78%, as Fractal’s AI solutions for diagnostics, drug research, and patient analytics gained traction globally. The BFSI sector also increased adoption of predictive analytics and data-driven decision-making tools.
Fractal improved profitability metrics, with adjusted EBITDA up 24% year‑on‑year and gross margins exceeding 47%, indicating efficient operations and strong cost management. The company’s net revenue retention stood at 114%, showing that existing clients increased their usage of Fractal’s products over time.
Fractal’s AI offerings have gained recognition internationally. Its Vaidya.ai 2.0 model scored above 50 on OpenAI’s HealthBench (Hard) benchmark for clinical reasoning, while its PiEvolve engine outperformed several global AI models in independent evaluations. These products have strengthened the company’s position in the competitive enterprise AI market.
With over 5,000 employees worldwide, Fractal is expanding its services across sectors including healthcare, BFSI, consumer goods, and technology. The strong quarterly performance highlights robust revenue growth, expanding margins, and increasing client engagement, setting the stage for continued growth and solidifying investor confidence in the company’s future.
Investors welcomed the results, and trading activity in Fractal’s shares increased following the quarterly announcement.
Also Read: Mazagon Dock shares jump on ₹99,000 cr defence contract hopes